Myocardial Ischemia Global Market Report 2024

Description

Myocardial ischemia, also known as cardiac ischemia, occurs when there is reduced blood flow to the heart muscle, resulting in insufficient oxygen and nutrient delivery. This condition can lead to potential damage to the heart muscle. The primary cause of myocardial ischemia is the narrowing of coronary arteries due to the buildup of plaque, which limits blood flow.

There are two main types of myocardial ischemia, symptomatic and asymptomatic. Symptomatic myocardial ischemia refers to cases where individuals experience symptoms such as chest pain or discomfort (angina) during episodes of reduced blood flow to the heart muscle. Various treatments and diagnostic approaches are utilized by different end-users including hospitals, clinics, diagnostic centers, and ambulatory surgery centers.

The myocardial ischemia market research report is one of a series of new reports from The Business Research Company that provides myocardial ischemia market statistics, including myocardial ischemia industry global market size, regional shares, competitors with a myocardial ischemia market share, detailed myocardial ischemia market segments, market trends, and opportunities, and any further data you may need to thrive in the myocardial ischemia industry. This myocardial ischemia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The myocardial ischemia market size has grown strongly in recent years. It will grow from $0.74 billion in 2023 to $0.79 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the utilization of telemedicine and remote monitoring, the development of novel reperfusion therapies for myocardial infarction (MI), increased cases of obesity, higher prevalence of high blood pressure, and an increase in the incidence of heart attacks.

The myocardial ischemia market size is expected to see strong growth in the next few years. It will grow to $1.04 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the prevalence of various heart-related diseases, increasing awareness among the population about cardiovascular diseases, evolving lifestyles, rising cases of diabetes, and higher healthcare expenditures. Major trends anticipated during this period include the adoption of advanced treatments for myocardial ischemia, improvements in healthcare infrastructure, advancements in treatment options, integration of digital health solutions, and the introduction of cardiac rehabilitation programs.

The increasing prevalence of diabetes is expected to drive growth in the myocardial ischemia market. Diabetes comprises a group of metabolic disorders characterized by the body's ineffective use of insulin, crucial for regulating blood sugar levels. Factors contributing to the rising incidence of diabetes include obesity, sedentary lifestyles, and genetic predisposition. This higher prevalence of diabetes correlates with increased occurrences of myocardial ischemia, prompting greater demand for diagnostic, therapeutic, and management solutions for this condition. For instance, the International Diabetes Federation reported in 2021 that approximately 537 million adults aged 20-79 worldwide had diabetes, a number projected to increase to 643 million by 2030 and 783 million by 2045. Thus, the rising incidence of diabetes serves as a catalyst for the myocardial ischemia market's expansion.

Key players in the myocardial ischemia market are focusing on developing innovative medications such as Lodoco (colchicine) to address inflammation and reduce cardiovascular risk in patients with coronary artery disease. Lodoco is specifically indicated to lower the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adults with established atherosclerotic disease or multiple cardiovascular risk factors. For example, Agepha Pharma, a US-based pharmaceutical firm, launched Lodoco (colchicine) in June 2023, following approval by the US Food and Drug Administration (FDA). This approval marked a significant milestone as the first FDA-approved treatment targeting cardiovascular inflammation. Clinical trials, including LoDoCo2, demonstrated a 31% relative risk reduction in cardiovascular events with colchicine 0.5 mg once daily compared to placebo. Lodoco is prescribed to mitigate the risk of serious cardiovascular events in eligible patients.

In December 2021, Pfizer, a prominent US-based pharmaceutical company, acquired Arena Pharmaceuticals for $6.7 billion, expanding its portfolio and capabilities in inflammation and immunology. This acquisition strengthens Pfizer's position in developing breakthrough treatments for immuno-inflammatory diseases, including myocardial ischemia. Arena Pharmaceuticals, a US biopharmaceutical firm, offers therapeutic solutions for myocardial ischemia.

Major companies operating in the myocardial ischemia market are Cardinal Health Inc., Pfizer Inc., Roche Holding AG, Bayer AG, Sanofi SA, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories Inc., Eli Lilly and Company, Novo Nordisk A/S, Medtronic Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Siemens Healthineers AG, Merck KGaA, GE HealthCare Technologies Inc., Fujifilm Holdings Corporation, Baxter International Inc., Regeneron Pharmaceuticals Inc., Boston Scientific Corporation, Daiichi Sankyo Company Limited, Canon Medical Systems Corporation

North America was the largest region in the myocardial ischemia market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the myocardial ischemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the myocardial ischemia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myocardial ischemia market consists of sales of statin, anticoagulants, and antiplatelet agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myocardial Ischemia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myocardial ischemia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myocardial ischemia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The myocardial ischemia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Symptomatic; Asymptomatic
2) By Treatment And Diagnosis: Diagnosis; Treatment
3) By End User: Hospitals And Clinics; Diagnostic Centers; Ambulatory Surgery Centers
Companies Mentioned: Cardinal Health Inc.; Pfizer Inc.; Roche Holding AG; Bayer AG; Sanofi SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18931

1. Executive Summary

2. Myocardial Ischemia Market Characteristics

3. Myocardial Ischemia Market Trends And Strategies

4. Myocardial Ischemia Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Myocardial Ischemia Market Size and Growth

5.1. Global Myocardial Ischemia Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Myocardial Ischemia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Myocardial Ischemia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Myocardial Ischemia Market Segmentation

6.1. Global Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Symptomatic
Asymptomatic
6.2. Global Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diagnosis
Treatment
6.3. Global Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Ambulatory Surgery Centers

7. Myocardial Ischemia Market Regional And Country Analysis

7.1. Global Myocardial Ischemia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Myocardial Ischemia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Myocardial Ischemia Market

8.1. Asia-Pacific Myocardial Ischemia Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Myocardial Ischemia Market

9.1. China Myocardial Ischemia Market Overview
9.2. China Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Myocardial Ischemia Market

10.1. India Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Myocardial Ischemia Market

11.1. Japan Myocardial Ischemia Market Overview
11.2. Japan Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Myocardial Ischemia Market

12.1. Australia Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Myocardial Ischemia Market

13.1. Indonesia Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Myocardial Ischemia Market

14.1. South Korea Myocardial Ischemia Market Overview
14.2. South Korea Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Myocardial Ischemia Market

15.1. Western Europe Myocardial Ischemia Market Overview
15.2. Western Europe Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Myocardial Ischemia Market

16.1. UK Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Myocardial Ischemia Market

17.1. Germany Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Myocardial Ischemia Market

18.1. France Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Myocardial Ischemia Market

19.1. Italy Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Myocardial Ischemia Market

20.1. Spain Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Myocardial Ischemia Market

21.1. Eastern Europe Myocardial Ischemia Market Overview
21.2. Eastern Europe Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Myocardial Ischemia Market

22.1. Russia Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Myocardial Ischemia Market

23.1. North America Myocardial Ischemia Market Overview
23.2. North America Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Myocardial Ischemia Market

24.1. USA Myocardial Ischemia Market Overview
24.2. USA Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Myocardial Ischemia Market

25.1. Canada Myocardial Ischemia Market Overview
25.2. Canada Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Myocardial Ischemia Market

26.1. South America Myocardial Ischemia Market Overview
26.2. South America Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Myocardial Ischemia Market

27.1. Brazil Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Myocardial Ischemia Market

28.1. Middle East Myocardial Ischemia Market Overview
28.2. Middle East Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Myocardial Ischemia Market

29.1. Africa Myocardial Ischemia Market Overview
29.2. Africa Myocardial Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Myocardial Ischemia Market, Segmentation By Treatment And Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Myocardial Ischemia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Myocardial Ischemia Market Competitive Landscape And Company Profiles

30.1. Myocardial Ischemia Market Competitive Landscape
30.2. Myocardial Ischemia Market Company Profiles
- 30.2.1. Cardinal Health Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Roche Holding AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Sanofi SA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Myocardial Ischemia Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca Plc
31.4. Abbott Laboratories Inc.
31.5. Eli Lilly and Company
31.6. Novo Nordisk A/S
31.7. Medtronic Plc
31.8. Boehringer Ingelheim International GmbH
31.9. Gilead Sciences Inc.
31.10. Siemens Healthineers AG
31.11. Merck KGaA
31.12. GE HealthCare Technologies Inc.
31.13. Fujifilm Holdings Corporation
31.14. Baxter International Inc.
31.15. Regeneron Pharmaceuticals Inc.

32. Global Myocardial Ischemia Market Competitive Benchmarking

33. Global Myocardial Ischemia Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Myocardial Ischemia Market

35. Myocardial Ischemia Market Future Outlook and Potential Analysis

35.1 Myocardial Ischemia Market In 2028 - Countries Offering Most New Opportunities
35.2 Myocardial Ischemia Market In 2028 - Segments Offering Most New Opportunities
35.3 Myocardial Ischemia Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer